Inge Lues

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study

Philip Scheltens, Merja Hallikainen, Timo Grimmer et al. · Alzheimer s Research & Therapy · 2018 · 132 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Two Mechanisms of Action of Racemic Cardiotonic EMD 53998, Calcium Sensitization and Phosphodiesterase Inhibition, Reside in Different Enantiomers

Inge Lues, Norbert Beier, Rochus Jonas et al. · Journal of Cardiovascular Pharmacology · 1993 · 79 citations

Medicine, Pharmacology, Physiology +14

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer’s Disease—Studies on Relation to Effective Target Occupancy

Torsten Hoffmann, Antje Meyer, Ulrich Heiser et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 74 citations · Full text

Life Sciences, Neuroscience, Pharmacology +14

Postjunctional ?-adrenoceptors in the isolated saphenous vein of the rabbit

Hans-Joachim Sch�mann, Inge Lues · Naunyn-Schmiedeberg s Archives of Pharmacology · 1983 · 68 citations

Life Sciences, Pharmacology, Physiology +6

The Novel Cardiotonic Agent EMD 53 998 is a Potent “Calcium Sensitizer”

Norbert Beier, Juergen Harting, Rochus Jonas et al. · Journal of Cardiovascular Pharmacology · 1991 · 65 citations

Medicine, Cardiology, Pharmacology +14